Loading...
NEW YORK (Reuters) - The U.S. telecommunications regulator is expected to announce plans on Thursday to set aside spectrum to connect wireless medical devices for more convenient health monitoring. The Federal Communications Commission said it is scheduled to vote on May 24 to adopt the plan for so-called Medical Body Area Networks, according to the telecom regulator, which has been working on the project for about two years. ...
WASHINGTON (Reuters) - U.S. crime statistics show illegal drugs play a central role in criminal acts, providing new evidence that tackling drugs as a public health issue could offer a powerful tool for lowering national crime rates, officials said on Thursday. An annual drug monitoring report, released by the White House Office of National Drug Control Policy, also showed a decline in the use of cocaine since 2003, a sign that drug-interdiction efforts and public education campaigns may be curtailing the use of the drug's powder and crack forms. ...
ATLANTA (Reuters) - The U.S. Centers for Disease Control and Prevention cut its threshold level for defining lead poisoning in children to 5 micrograms per deciliter on Wednesday from 10, marking the first such reduction in 20 years. "The recommendation was based on a growing number of scientific studies showing that even low blood lead levels can cause lifelong health effects," the CDC said, in adopting the recommendation of an advisory committee. "Today, CDC is officially announcing our agreement with that recommendation. ...

A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster(Reuters) - Adding Johnson & Johnson's advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease. The mid-stage trial found that six months of treatment with the combination therapy completely or nearly eliminated the cancer in a third of patients, all of whom had localized, aggressive cancer. ...


A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster(Reuters) - Adding Johnson & Johnson's advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease. The mid-stage trial found that six months of treatment with the combination therapy completely or nearly eliminated the cancer in a third of patients, all of whom had localized, aggressive cancer. ...


WEDNESDAY, May 16 (HealthDay News) -- A preliminary, first-stage study funded by a pharmaceutical company shows promising results for an experimental double-drug therapy for melanoma.
WEDNESDAY, May 16 (HealthDay News) -- Drug company researchers say they've determined which multiple sclerosis patients are most vulnerable to developing a rare brain infection while taking a powerful drug called Tysabri (natalizumab).
WEDNESDAY, May 16 (HealthDay News) -- A new targeted drug therapy may help treat certain advanced cancers in children, a new preliminary study indicates.
WEDNESDAY, May 16 (HealthDay News) -- The widely prescribed antibiotic azithromycin may slightly raise the risk of death in patients with heart disease, a new study suggests.
WEDNESDAY, May 16 (HealthDay News) -- A drug approved to treat advanced prostate cancer appears to help men who have localized high-risk prostate cancer if given before surgery.

Sponsors

Top Contributors

EM @ KING.NET (12744)

Sponsors

Sponsors

Share